ArticleJournal of virology2018

A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs.

Erik Abner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.